Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3944343 | Gynecologic Oncology | 2008 | 6 Pages |
Abstract
This may be the largest personal experience of this rare cancer reported to date. Results with an aggressive multi-modality approach exceed results in low stage disease compared to recently reported series. Of the total of 53 personal cases treated, this report focuses on the 24 where, irrespective of clinical stage, all gross disease could be excised, and therapy then added for occult disease control. The author's evolving experience suggests that the use of aggressive and complete bulk-reductive surgery followed by both chemotherapy and extended field radiation therapy may offer a therapeutic advantage in the management of this rare disease.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Richard C. Boronow,